GTX-B001 clinical trials

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

This study is looking at a new medicine called GTX-B001 for people with constant a particular type of hives called chronic inducible urticaria (like cold hives or hives from scratching). It aims to check if the medicine is safe and if it helps reduce symptoms.